Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma

the Canadian Brain Tumour Consortium, on behalf of the BI 1200.36 Trial Group

Research output: Contribution to journalArticlepeer-review

134 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences